Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview

BACKGROUND: Therapeutic drug monitoring involves therapeutic modifications based on the measurement of drug levels and antidrug antibodies. The viability of therapeutic drug monitoring in vedolizumab-treated patients with inflammatory bowel disease remains questioned. MAIN BODY: Accumulating evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pouillon, Lieven, Vermeire, Séverine, Bossuyt, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505179/
https://www.ncbi.nlm.nih.gov/pubmed/31064370
http://dx.doi.org/10.1186/s12916-019-1323-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505179/
https://www.ncbi.nlm.nih.gov/pubmed/31064370
http://dx.doi.org/10.1186/s12916-019-1323-8

Ejemplares similares